Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1990 Feb;45(2):100–104. doi: 10.1136/thx.45.2.100

In vitro and in vivo effects of ribavirin on human respiratory epithelium.

L Y Han 1, R Wilson 1, S Slater 1, A Rutman 1, R C Read 1, N J Snell 1, P J Cole 1
PMCID: PMC462315  PMID: 2315872

Abstract

The effects of ribavirin, a broad spectrum antiviral agent, on the structure and function of normal human nasal epithelium have been studied in vitro, as has also the in vivo effect of treatment with nebulised ribavirin on nasal mucociliary clearance of saccharin in four patients. Ciliary beat frequency was measured by a photometric technique, and changes in epithelial and ciliary ultrastructure were assessed by transmission electron microscopy. Ribavirin solution at the recommended concentration of 20 mg/ml had no adverse effects on ciliary activity in vitro; at concentrations of 50 mg/ml and above it slowed ciliary beating significantly and at 60 mg/ml caused ciliostasis associated with epithelial disruption. Nasal inhalation of ribavirin at 60 mg/ml for up to 20 minutes, however, did not slow nasal mucociliary clearance, nor did it adversely affect the ciliary beating or structure of nasal ciliated epithelium examined in vitro immediately after inhalation.

Full text

PDF
100

Images in this article

103Image
on p.103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balmes J. R., Fine J. M., Christian D., Gordon T., Sheppard D. Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. Am Rev Respir Dis. 1988 Jul;138(1):35–39. doi: 10.1164/ajrccm/138.1.35. [DOI] [PubMed] [Google Scholar]
  2. Barry W., Cockburn F., Cornall R., Price J. F., Sutherland G., Vardag A. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child. 1986 Jun;61(6):593–597. doi: 10.1136/adc.61.6.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crumpacker C., Heagy W., Bubley G., Monroe J. E., Finberg R., Hussey S., Schnipper L., Lucey D., Lee T. H., McLane M. F. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation. Ann Intern Med. 1987 Nov;107(5):664–674. doi: 10.7326/0003-4819-107-5-664. [DOI] [PubMed] [Google Scholar]
  4. Hall C. B., McBride J. T., Walsh E. E., Bell D. M., Gala C. L., Hildreth S., Ten Eyck L. G., Hall W. J. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med. 1983 Jun 16;308(24):1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  5. Hirsch M. S., Kaplan J. C. Treatment of human immunodeficiency virus infections. Antimicrob Agents Chemother. 1987 Jun;31(6):839–843. doi: 10.1128/aac.31.6.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Holma B., Lindegren M., Andersen J. M. pH effects on ciliomotility and morphology of respiratory mucosa. Arch Environ Health. 1977 Sep-Oct;32(5):216–226. doi: 10.1080/00039896.1977.10667285. [DOI] [PubMed] [Google Scholar]
  7. Huffman J. H., Sidwell R. W., Khare G. P., Witkowski J. T., Allen L. B., Robins R. K. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother. 1973 Feb;3(2):235–241. doi: 10.1128/aac.3.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaliner M., Austen K. F. Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol. 1974 Feb;112(2):664–674. [PubMed] [Google Scholar]
  9. Knight V., McClung H. W., Wilson S. Z., Waters B. K., Quarles J. M., Cameron R. W., Greggs S. E., Zerwas J. M., Couch R. B. Ribavirin small-particle aerosol treatment of influenza. Lancet. 1981 Oct 31;2(8253):945–949. doi: 10.1016/s0140-6736(81)91152-1. [DOI] [PubMed] [Google Scholar]
  10. Liss H. P., Bernstein J. Ribavirin aerosol in the elderly. Chest. 1988 Jun;93(6):1239–1241. doi: 10.1378/chest.93.6.1239. [DOI] [PubMed] [Google Scholar]
  11. Luk C. K., Dulfano M. J. Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin Sci (Lond) 1983 Apr;64(4):449–451. doi: 10.1042/cs0640449. [DOI] [PubMed] [Google Scholar]
  12. Marquardt D. L., Gruber H. E., Walker L. L. Ribavirin inhibits mast cell mediator release. J Pharmacol Exp Ther. 1987 Jan;240(1):145–149. [PubMed] [Google Scholar]
  13. McClung H. W., Knight V., Gilbert B. E., Wilson S. Z., Quarles J. M., Divine G. W. Ribavirin aerosol treatment of influenza B virus infection. JAMA. 1983 May 20;249(19):2671–2674. [PubMed] [Google Scholar]
  14. McCormick J. B., Getchell J. P., Mitchell S. W., Hicks D. R. Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet. 1984 Dec 15;2(8416):1367–1369. doi: 10.1016/s0140-6736(84)92060-9. [DOI] [PubMed] [Google Scholar]
  15. McCormick J. B., King I. J., Webb P. A., Scribner C. L., Craven R. B., Johnson K. M., Elliott L. H., Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986 Jan 2;314(1):20–26. doi: 10.1056/NEJM198601023140104. [DOI] [PubMed] [Google Scholar]
  16. Prieto J., Sangro B., Beloqui O. Ribavirin in desquamative interstitial pneumonia. Chest. 1988 Feb;93(2):446–447. doi: 10.1378/chest.93.2.446b. [DOI] [PubMed] [Google Scholar]
  17. Rutland J., Cole P. J. Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure. Lancet. 1980 Sep 13;2(8194):564–565. doi: 10.1016/s0140-6736(80)91995-9. [DOI] [PubMed] [Google Scholar]
  18. Schoeffel R. E., Anderson S. D., Altounyan R. E. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J (Clin Res Ed) 1981 Nov 14;283(6302):1285–1287. doi: 10.1136/bmj.283.6302.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stanley P., MacWilliam L., Greenstone M., Mackay I., Cole P. Efficacy of a saccharin test for screening to detect abnormal mucociliary clearance. Br J Dis Chest. 1984 Jan;78(1):62–65. [PubMed] [Google Scholar]
  20. Wilson R., Sykes D. A., Currie D., Cole P. J. Beat frequency of cilia from sites of purulent infection. Thorax. 1986 Jun;41(6):453–458. doi: 10.1136/thx.41.6.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wilson S. Z., Gilbert B. E., Quarles J. M., Knight V., McClung H. W., Moore R. V., Couch R. B. Treatment of influenza A (H1N1) virus infection with ribavirin aerosol. Antimicrob Agents Chemother. 1984 Aug;26(2):200–203. doi: 10.1128/aac.26.2.200. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES